Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
252.16 USD | -0.77% |
|
-1.65% | +10.35% |
04:42pm | RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 | MT |
09/07 | Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing | MT |
ETFs positioned on ResMed, Inc.
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
1.09% | 21 M€ | +4.65% | - | |
0.43% | 6 M€ | 0.00% | - | |
0.43% | 0 M€ | -.--% | - | |
0.38% | 3 M€ | -.--% | - | |
0.34% | 0 M€ | -.--% | - | |
0.33% | 131 M€ | +6.40% | - | |
0.21% | 153 M€ | +7.61% | - | |
0.2% | 13 M€ | +2.26% | - | |
0.2% | 0 M€ | -.--% | - | |
0.18% | 0 M€ | -.--% | - | |
0.18% | 0 M€ | -.--% | - | |
0.16% | 0 M€ | -.--% | - | |
0.1% | 34,382 M€ | +0.25% | - | |
0.1% | 192 M€ | +2.70% | - |
Employees
9,980
Calendar
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
254.11USD
Average target price
264.49USD
Spread / Average Target
+4.08%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
- ETFs ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition